Publication Topic

Becker RA, Patlewicz G, Simon T, Rowlands JC, Budinsky RA. 2015. The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor. Regul Toxicol Pharmacol 73(1):172-190; doi: 10.1016/j.yrtph.2015.06.015. PMID: 26145830.

Petkov P, Patlewicz G, Schultz TW, Honma M, Todorov M, Kotov S, Dimitrov SD, Donner EM, Mekenyan OM. 2015. A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity? Regul Toxicol Pharmacol 72(1):17-25; doi: 10.1016/j.yrtph.2015.03.003. PMID: 25792138.

Patlewicz G, Ball N, Boogaard P, Becker RA, Hubesch B. 2015. Building scientific confidence in the development and evaluation of read-across. Regul Toxicol Pharmacol 72(1):117-133; doi: 10.1016/j.yrtph.2015.03.015. PMID: 25857293.

Patlewicz G, Simon T, Rowlands JC, Budinsky R, Becker RA. 2015. Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes. Regul Toxicol Pharmacol 71(3):463-477; doi: 10.1016/j.yrtph.2015.02.011. PMID: 25707856. (Top 10 Paper for RASS Award at SOT 2016)

Tice R, Allen D, Choksi N, Truax J, Stokes W. Relationship between adverse ocular effects and their reversibility. Poster presented at the 6th World Congress on Alternatives and Animal Use in the Life Sciences, Tokyo, Japan, August 2007.